Noninvasive assessment of HIV-related coronary artery disease

Area of Science:

• Cardiology
• Infectious Diseases
• Medical Imaging

Background:

• Highly active antiretroviral therapy (HAART) has reduced HIV mortality but increased cardiovascular disease (CVD) risk.
• CVD in HIV patients stems from traditional risk factors, HIV-specific elements, antiretroviral therapy, inflammation, and viral effects.
• Accurate cardiovascular risk assessment in HIV patients is a clinical challenge.

Purpose of the Study:

• To review noninvasive vascular imaging techniques for cardiovascular risk assessment in HIV patients.
• To aid practitioners in identifying high-risk HIV individuals for targeted therapy.
• To explore how imaging can help reduce cardiac events in this population.

Main Methods:

• Review of current noninvasive vascular imaging modalities.
• Analysis of their utility in assessing cardiovascular risk in HIV-infected individuals.
• Synthesis of evidence to guide clinical practice.

Main Results:

• Noninvasive vascular imaging offers enhanced capabilities for cardiovascular risk stratification in HIV patients.
• These techniques can identify individuals at higher risk, enabling proactive management.
• The review examines specific imaging tests relevant to this population.

Conclusions:

• Noninvasive vascular imaging is crucial for comprehensive cardiovascular risk assessment in HIV patients.
• Utilizing these tools can lead to more effective, targeted interventions.
• Improved risk assessment and management can mitigate cardiac events in the HIV population.